default author photo

Lucie Ecker

Instituto de Investigación Nutricional

Lima

Peru

  • Instituto de Investigación Nutricional

SCHOLARLY PAPERS

4

DOWNLOADS

1,806

TOTAL CITATIONS

10

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America

Number of pages: 29 Posted: 27 Aug 2021
Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana, Gustavo Jose Aroca Martinez, Marc J.M. Bonten, Reynaldo Chandler, Gonzalo Corral, Eddie Jan Louis De Block, Lucie Ecker, Julian Justin Gabor, Carlos Alberto Garcia Lopez, Lucy Gonzales, María Angélica Granados González, Nestor Gorini, Martin P. Grobusch, Martin P. Grobusch, Adrian D. Hrabar, Helga Junker, Alan Kimura, Claudio F. Lanata, Clara Lehmann, Isabel Leroux-Roels, Philipp Mann, Michel Fernando Martinez-Reséndez, Theresa Ochoa, Carlos Alberto Poy, Maria Jose Reyes Fentanes, Luis Maria Rivera Mejia, Vida Veronica Ruiz Herrera, Xavier Sáez-Llorens, Oliver Schönborn-Kellenberger, Mirjam Schunk, Alexandra Sierra Garcia, Itziar Vergara, Thomas Verstraeten, Marisa Vico, Lidia Oostvogels and HERALD Study Group
Lambaréné Medical Research Center (CERMEL), Lambaréné, Corporacion Medica de General San Martin, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Universidad Simón Bolívar (USB) - Clínica de la Costa, Utrecht University - Julius Center for Health Sciences and Primary Care, Cevaxin, Instituto de Investigaciones Clinicas de Mar del Plata, Cohezio, Instituto de Investigación Nutricional, University of Tübingen - Institute of Tropical Medicine, Unidad de Medicina Especializada, Clinica Medica San Martin, Centro de Atención e Investigación Médica (CAIMED), Hospital Zonal General de Agudos Descentralizado Evita Pueblo de Berazategui, Lambaréné Medical Research Center (CERMEL), LambarénéUniversity of Amsterdam - Amsterdam Institute for Infection and Immunity, Clinical Research Institute Quilmes (Instituto de Investigaciones Clínicas Quilmes), CureVac AG, CureVac AG, Instituto de Investigación Nutricional, University of Cologne - Division of Infectious Diseases, Ghent University - Center for Vaccinology (CEVAC), CureVac AG, TecSalud - School of Medicine and Health Sciences, Universidad Peruana Cayetano Heredia - Instituto de Medicina Tropical Alexander von Humboldt, Sanatorio Parque S.A. Rosario, PanAmerican Clinical Research, Hospital Universitario Maternidad Nuestra Señora de La Altagracia - Fundacion Dominicana de Perinatologia PRO-BEBE, Inc., PanAmerican Clinical Research, Hospital del Niño Dr. José Renán Esquivel, Cogitars GmbH, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Centro de estudios en Infectologia Pediatrica (CEIP), Biodonostia Health Research Institute - Primary Care Group, P95 Pharmacovigilance and Epidemiology Services, Instituto de Investigaciones Clínicas Zárate, CureVac AG and Independent
Downloads 1,572 (29,255)
Citation 9

Abstract:

Loading...

CVnCoV mRNA vaccine; SARS-CoV-2; COVID-19; adults; randomised clinical trial

2.

Safety and Immunogenicity of mRNA-LNP COVID-19 Vaccine CVnCoV in Latin American Adults; A Phase 2 Randomized Study

Number of pages: 33 Posted: 30 Dec 2021
Xavier Sáez-Llorens, Claudio F. Lanata, Elaine Aranguren, Carlos R. Celis, Rubelio Cornejo, Rodrigo DeAntonio, Lucie Ecker, Diegi Garrido, Ana I. Gil, Marina Gonzales, Morgan Hess-Holtz, Geert Leroux-Roels, Helga Junker, Sarah-Katharina Kays, Sven D. Koch, Sandra Lazzaro, Philipp Mann, Gianluca Quintini, Barkha Srivastava, Dominik Vahrenhorst, Philipp von Eisenhart-Rothe, Olaf-Oliver Wolz and Lidia Oostvogels
Cevaxin, Instituto de Investigación Nutricional, Cevaxin, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Cevaxin, Instituto de Investigación Nutricional, Cevaxin, Instituto de Investigación Nutricional, CureVac AG, Cevaxin, Ghent University - Ghent University Hospital, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG, CureVac AG and CureVac AG
Downloads 133 (547,695)
Citation 1

Abstract:

Loading...

COVID-19, vaccine, mRNA, clinical trial

3.

SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study

Number of pages: 20 Posted: 22 Nov 2021
Claudio F. Lanata, Ana I. Gil, Lucie Ecker, Rubelio Cornejo, Stefano Rios, Mayra Ochoa, Bia Peña, Omar Flores, Leigh M. Howard and Carlos G. Grijalva
Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Vanderbilt University - Medical Center and Vanderbilt University - Medical Center
Downloads 62 (942,565)

Abstract:

Loading...

SARS-CoV-2, COVID-19, incidence, cohort, Peru

4.

Pooling of Respiratory Samples for the Detection of SARS-CoV-2: A Validation and Cost Study in a Cohort in Lima, Peru

Number of pages: 19 Posted: 24 Feb 2023
Mayra Ochoa, Bia Peña, Omar Flores, Ana I. Gil, Lucie Ecker, Rubelio Cornejo, Leigh M. Howard, Carlos G. Grijalva and Claudio F. Lanata
Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Instituto de Investigación Nutricional, Vanderbilt University - Medical Center, Vanderbilt University - Medical Center and Instituto de Investigación Nutricional
Downloads 39 (1,196,171)

Abstract:

Loading...

SARS-CoV-2, Nasal swab, saliva sample, sample pools, cost, validation